Home Your basket
• Early PTH assay after tot...
   Price 10.50 €
• Early evaluation of voice...
   Price 12.00 €
• Reconstruction of a trans...
   Price 8.50 €
• Carotid body paragangliom...
   Price 8.50 €
• A new technique for the u...
   Price 5.50 €
• Diagnosis of submandibula...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Transsexualism: From diag...
   Price 10.50 €
• When some clinical cases ...
   Price 8.50 €
• Middle ear adenoma / carc...
   Price 8.50 €
• Speech disorders, verbal ...
   Price 10.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• Voice Handicap Index adap...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Evolution of the otology ...
   Price 5.50 €
• Posterior cranial fossa a...
   Price 8.50 €
• Audit of headache followi...
   Price 5.50 €
• Management of swallowing ...
   Price 8.50 €
• Tumours of the accessory ...
   Price 10.50 €
• Otologic surgery in HIV-i...
   Price 8.50 €
• Mucus physiopathology, up...
   Price 12.50 €
• Total pharyngolayngectomy...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 8.50 €
• Acceptability of topical ...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Audiological comparison b...
   Price 14.00 €
• Stapedotomy and anatomica...
   Price 5.50 €
• Fungal sinusitis: Report ...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €

Total Order 256.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2003 o

CERVICO-FACIAL SURGERY

Interest of the cervical gland dissection after radiotherapy with or without chemotherapy.


Authors : Th. Houliat, D. N'Guyen, L. Eimer, B. Baltazart, C. Convert, K. Diallo, J. Meynard, L. Traissac (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2003;124,2:127-134.

Article published in french
Downloadable PDF document french



Summary : Objectives: The aim of this study was to evaluate the necessity and morbidity of neck dissection after radiation therapy within organ preservation treatment. Patients and methods: We present a retrospective study of 64 patients, treated initially by radiotherapy with or without chemotherapy for squamous cell carcinoma of head and neck with cervical metastases (> 2cm), who underwent post-radiation neck dissection between January 1992 and August 2000. Eight (13%) patients were classified T1, nineteen (30%) T2, twenty (31%) T3, eleven (17%) T4 and six (9%) Tx. Eleven patients had N1 neck disease (17%), fifteen patients N2a (24 %), eleven patients N2b (17%) and twenty-seven patients N3 (42%). Results: Follow-up ranged from 3 to 86 months with a mean of 39 months. The average length of time between neck dissection and the end of treatment was 60 days. Complications were recorded in 21 patients (33%). Forty-four (68%) of 64 patients had microscopic residual disease. Eight (72%) of 11 patients with N1 neck disease and 17 (63%) of 27 patients with N3 neck disease had pathology. Initial N status was not a predictive factor of microscopic residual disease (p=0.51). There was no significant relationship between clinical residual adenopathy and microscopic residual disease (p=0.53). Fourteen patients are still alive without recurrent disease. Eight (57%) of these 14 patients had a positive pathology at the time of neck dissection. The mean follow-up time of these patients is 32.6 months, with a follow up longer than 2 years for half of them (n=7). Conclusion: Neck dissection after radiation was planned for all patients with an initial node > 2 cm in diameter regardless of clinical response in the neck. We confirm that neck dissection appears to be safe after radiotherapy and is necessary because it improves quality of life and prevents fatal evolution with uncontrollable neck disease.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE